Your browser does not support java script. Skip navigation
Loading, please wait  Loading, please wait...

(8:00 am): Beta Cells: Teplizumab T1 Diabetes


Microsoft Teams meeting
Meeting ID: 231 945 732 904 642
Passcode: aK28zs9x

Dial in by phone
+1 470-344-8779,,116261022# United States, Atlanta
Phone conference ID: 116 261 022#
For organizers: Meeting options | Reset dial-in PIN

Date: Jun 11, 2026 07:30 AM - 08:30 AM

Fee

$0.00

CE Hours

2.00

CE Units

0.200

Registration closes on Jun 18, 2026 12:00 AM

Activity Type

  • Application

Target Audience(s)

  • Pharmacists
  • Pharmacy Technicians

Accreditation(s)

Accreditation Council for Pharmacy Education
 WellStar Health System is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

Requirements for CE Credit

Participants who attend the entire activity, complete and pass the post-test (>70%), and complete the activity evaluation will receive CE credit. Credit will be uploaded electronically and available in CPE Monitor after completion of required elements.

 

 

Thu, Jun 11, 2026
 

   

Microsoft Teams meeting
Meeting ID: 231 945 732 904 642
Passcode: aK28zs9x

Dial in by phone
+1 470-344-8779,,116261022# United States, Atlanta
Phone conference ID: 116 261 022#
For organizers: Meeting options | Reset dial-in PIN

Objectives

  • Describe the pathophysiology and staging of Type 1 diabetes, including the role of autoimmune ?-cell destruction.
  • Recognize the mechanism of action and clinical effects of teplizumab in delaying disease progression.
  • Identify patients at risk for progression to Stage 3 Type 1 diabetes and appropriate candidates for teplizumab therapy.
  • Apply evidence-based strategies for the use, monitoring, and management of teplizumab in clinical practice.

Speaker(s)/Author(s)

Mariam Diaby, PharmD
PGY1 Pharmacy Resident, Wellstar Cobb Medical Center

Activity Number

0483-0000-26-008-L01-P
Date: 06/11/26
Time: 07:30 AM - 08:30 AM

CE Hours

1.00

Location

Wellstar Cobb Auditorium and MS Teams
   

   

Microsoft Teams meeting
Meeting ID: 231 945 732 904 642
Passcode: aK28zs9x

Dial in by phone
+1 470-344-8779,,116261022# United States, Atlanta
Phone conference ID: 116 261 022#
For organizers: Meeting options | Reset dial-in PIN

Objectives

  • Describe the purpose and basic mechanism of teplizumab in delaying Type 1 diabetes
  • Recognize common adverse effects and the importance of monitoring during therapy
  • Explain the basic administration process and infusion considerations for teplizumab

Speaker(s)/Author(s)

Mariam Diaby, PharmD
PGY1 Pharmacy Resident, Wellstar Cobb Medical Center

Activity Number

0483-0000-26-008-L01-T
Date: 06/11/26
Time: 07:30 AM - 08:30 AM

CE Hours

1.00

Location

Wellstar Cobb Auditorium and MS Teams